0365 : Risk markers of cardiac events in patients with Marfan syndrome diagnosed during childhood  by Hascoët, Sébastien et al.
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2015) 7, 213-215 213
Topic 39 – Surgery
0360
Iatrogenic circumflex artery occlusion during mitral valve surgery: a
retrospective study on 8 patients and a medical review
Grégoire Cauchois, Matthieu Godin, Fabien Doguet, Hélène Eltchaninoff,
Jean-Paul Bessou, Eric Durand, François Bouchart, Christophe Tron
CHU Charles Nicolle, Cardiologie, Rouen, France
Background: Circumflex coronary artery (CCA) injury during mitral
valve surgery is a rare but serious complication whit difficult diagnosis. The
aim of our study was to describe the elements of diagnosis that could allow
prevention of this complication.
Methods and Results: From 2006 to 2013 in Rouen University Hospital, 8
patients (1.03%) among 775 undergoing mitral valve surgery (repair or replace-
ment) presented CCA occlusion confirmed by coronary angiography. Sex ratio
was 5 men for 3 women with a mean age of 54.2 years. Left main coronary
dominance was present in 75%. Mitral valve repair was performed in 5 patients
and valve replacement in 3. The diagnosis was suspected by ECG in 7/8
patients: 6 patients (75%) presented ST segment elevation, 1 had permanent AV
block while EKG was normal in one. CCA occlusion led to a significant impair-
ment of left ventricular function, median LVEF: decreased from 58 to 43%
(p=0.04) although coronary angiography was performed within one hour in 5
patients (62.5%). Five had complete revascularization (4 of those with imme-
diate coronary angiography), while 3 patients were treated medically.
Occlusion, assessed by coronary angiography, was preferentially located
on the superolateral quarter of the mitral annulus next to the anterolateral com-
missure predominantly on its mid portion (75%). As regards to the mechanism
of CCA occlusion, 37.5% of patients had a stitch passing through the CCA,
50% had a kinking of the vessel due to a stitch located close to the CCA and
one of them had a compressive hematoma
Follow-up at day-7 was uneventful in 7 patients with one in-hospital death
one day after the surgery (cardiac tamponade).
Conclusion: CCA injury is a rare but serious complication of mitral valve sur-
gery suspected on ECG, due to a stitch always located at the same point of mitral
annulus. An eventual intraoperative angiography in hybrid rooms could be a spe-
cific solution for patients at risk (large mitral ring, left main coronary dominance).
Abstract 0360-Figure: Occlusion of the circumflex coronary artery
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Objectives: Life expectancy of patients with Marfan syndrome has
increased, due to earlier diagnosis, better familial screening, regular follow-up
(FU) and prophylactic aortic surgery (PASu). Incidence of events in affected
patients recognized during childhood is unknown.
Methods: 465 patients with Marfan syndrome, diagnosed before 18y.o.
were included in the French multicenter database. Cardio-vascular events
(death, aortic dissection or PASu) were recorded
Results: A cardio-vascular event occurred in 25 patients (5.4% 95CI 3.5-
7.8%), including PASu (n=20, 4.3% 95CI 2.5-6.2%), aortic dissection (n=3,
0.6% 95CI 0.0-1.4%) and deaths (n=2, 0.4% 95CI 0.0-1.0%). 16 events (64%)
occurred before 19 year-old (Median 15.0, min 2.8, interquartile 11.7-16.3;
PASu n=12, deaths n=2 and dissection n= 2). An aortic surgery was per-
formed in 23 patients (4.9%, 95CI 3.0-6.9%), including a Bentall procedure
with mechanical aortic valve in 10 (43.5%), a valve sparing surgery in the
remaining 13 (56.5%) and a supra-coronary graft in 4 (17.4%, dissection: n=2
and PASu: n=2). Mean age at the date of PASu was 17.1±6.5 year-old. Events
occurred before or at inclusion in the database in 8 patients (32.0%) (PASu
n=5, dissection n=2, death n=1). Dissection was observed before inclusion in
2 patients and during pregnancy in 1 patient. Kaplan-Meier survival estimate
indicates that 95% of patients remained free from events at eighteen and 78%
at thirty year-old.
Conclusion: Prophylactic surgery for enlarged aorta is the main cause of car-
diac events in patients with Marfan syndrome diagnosed during childhood. A
quarter of them have a cardiac event before thirty year-old.
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Objectives: Risk markers of cardio-vascular events in children with Marfan
syndrome remain little known. We assessed the prognostic value of aortic root
z-score in patients with Marfan syndrome diagnosed during childhood.
Methods: From the French multicenter database, 457 patients with Marfan
syndrome, diagnosed before 18 y.o., were prospectively included in this
cohort study. Echocardiographic measurements of aortic root diameters were
performed at each visit. We calculated the Z-score of aortic root measure-
ments using the Bichat formula. Mean z-score was defined as the mean of the
z-score (MeanZS15) calculated for each measurement before the age of 16.
Results: Median age at end of FU was 15.9years (interquartile 10.9-20.3).
FU was complete for 69.5% of patients. Median FU was 4.6years. A cardio-
vascular event occurred in 17 patients (3.7%, prophylactic aortic surgery
n=14, aortic dissection n=1 and deaths n=2). Survival free of cardiac events
was 85.1% in patients with a meanZS15 of the Valsalva diameter <3 and
56.4% in patients with a meanZS15 of the Valsalva diameter ≥3 (p<0.0001 by
log-rank test). In univariate analysis, Valsalva meanZS15 ≥3, age at inclusion
in the database, a lower heart rate and an increased arm/height ratio were asso-
ciated with an increasing risk of cardiac events (p<0.0001, p=0.04, p=0.01 and
p=0.04 respectively). After multivariate adjustment using a cox proportional
hazards model, only Valsalva meanZS15 ≥3 and lack of FBN1 or TGBB
mutation identified were associated with an increasing risk of cardiac events,
p<0.0001 and p=0.04 respectively).
Conclusion: Valsalva meanZS15 may help to identify high-risk children.
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Background: Despite the absence of randomized studies comparing mitral
valve (MV) repair and replacement, international guidelines strongly recom-
mend MV repair as the optimal surgical treatment for severe degenerative
mitral regurgitation (dMR). Yet, the level of evidence supporting these recom-
mendations is low, owing to the lack of available clinical trial data. In this
context, analysis of large multicenter registries becomes critical.
Objective: To compare very long-term survival among patients (pts)
undergoing MV repair versus replacement for the treatment of severe dMR
using the technique of propensity score (PS) matching to reduce bias in non-
randomized cohorts.
Methods: The Mitral Regurgitation International DAtabase (MIDA) is a
prospective multicenter registry that includes 2,569 consecutive pts with dMR,
who were recruited in 6 tertiary centers (France, Italy, Belgium, and the
United States) between 1980 and 2005. Among these, we identified 1,922 pts
who underwent mitral surgery, including 1,709MV repairs and 213MV
replacements. We compared operative mortality and overall survival in both
the entire study population and in 615 PS-matched (2:1) pts.
Results: Operative mortality was lower after MV repair than after MV
replacement, both in the entire population (2 vs 7%; p=0.001) and in the PS-
matched pts (4 vs 8%; p=0.04). Similarly, 20-year survival was better after
MV repair than after MV replacement, both in the entire population (46%
[(95% CI, 39%-52%] vs 23% [95% CI, 14%-32%], p<0.001) and in the PS-
matched pts (41% [95% CI, 28%-54%] vs 24% [95% CI, 14%-33%],
p<0.001). Similar results were obtained in pts aged < 65 years (p<0.005), 65-
74 years (p<0.001) and ≥75 years (p<0.001). 
Conclusions: Among registry pts with dMR, performance of MV repair
resulted in lower operative mortality and greater long-term survival compared
to MV replacement, thus supporting current international recommendations.
Abstract 0365-Figure: K. M Survival estimate without cardiovascular events
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